Profile data is unavailable for this security.
About the company
Capstone Therapeutics Corp., formerly Capstone Holding Corp., operates, through its wholly owned subsidiary, TotalStone, LLC, which is a construction materials company. TotalStone, LLC distributes masonry stone products for residential and commercial construction in the Midwest and Northeast United States. The Company, through its subsidiary, Capstone Beta, LLC, owns an equity interest in Diamond Products, LLC, which is a sexual wellness products holding company. Diamond Products, LLC product portfolio includes adult toys, lingerie, games, lotions and creams that are sold globally in over 80 countries through 5,000 retailers, as well as e-commerce Websites.
- Revenue in USD (TTM)0.00
- Net income in USD-358.00k
- Incorporated2008
- Employees2.00
- LocationCapstone Therapeutics CorpSUITE 101, 1275 WEST WASHINGTON STREETTEMPE 85281United StatesUSA
- Phone+1 (602) 286-5520
- Fax+1 (302) 655-5049
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Endonovo Therapeutics Inc | 255.72k | -4.40m | 524.09k | 0.00 | -- | -- | -- | 2.05 | -0.0652 | -0.0652 | 0.0003 | -0.072 | 0.2256 | -- | -- | -- | -388.54 | -303.26 | -- | -- | 96.21 | 74.38 | -1,722.26 | -5,956.27 | -- | -1.38 | -- | -- | 85.15 | -- | -495.02 | -- | -- | -- |
| Pharmagreen Biotech Inc | 1.56k | -500.66k | 530.92k | 0.00 | -- | -- | -- | 340.33 | -0.0011 | -0.0011 | 0.00 | -0.0045 | 0.0094 | -- | 3.35 | -- | -302.10 | -472.20 | -- | -- | 11.54 | -- | -32,096.15 | -- | 0.0194 | -71.71 | -- | -- | -- | -- | 80.68 | -- | -- | -- |
| Hanyuan Biotech International Inc | 10.65m | 3.14m | 539.39k | -- | 0.0294 | 0.0064 | 0.1481 | 0.0506 | 0.2246 | 0.2246 | 0.7611 | 1.03 | -- | -- | -- | -- | -- | -- | -- | -- | 68.54 | -- | 29.51 | -- | 13.36 | 25.66 | 0.00 | -- | 50.51 | -- | 106.71 | -- | -- | -- |
| Limitless X Holdings Inc | 14.21m | -8.40m | 597.62k | 12.00 | -- | -- | -- | 0.0421 | -2.10 | -2.10 | 3.58 | -3.51 | 3.73 | 1.77 | 14.40 | 1,184,068.00 | -220.35 | -- | -- | -- | 77.76 | -- | -59.15 | -- | 0.0173 | -9.02 | -- | -- | -65.83 | -- | -60.80 | -- | -- | -- |
| Molecular Pharmacology (USA) Ltd | 0.00 | -105.18k | 599.73k | 0.00 | -- | -- | -- | -- | -0.0009 | -0.0009 | 0.00 | -0.0188 | 0.00 | -- | -- | -- | -976.60 | -1,219.29 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 44.29 | -- | -- | -- |
| International Stem Cell Corp | 7.83m | -327.00k | 644.35k | 29.00 | -- | -- | -- | 0.0823 | -0.0409 | -0.0409 | 0.9785 | 0.0045 | 1.46 | 2.53 | 11.87 | 270,069.00 | -5.81 | -29.22 | -68.13 | -73.82 | 58.58 | 59.49 | -3.97 | -21.01 | 0.4672 | -6.06 | 0.9898 | -- | -4.78 | -6.82 | 60.42 | -- | -34.45 | -- |
| Capstone Therapeutics Corp | 0.00 | -358.00k | 646.20k | 2.00 | -- | -- | -- | -- | -6.58 | -38.12 | 0.00 | -60.70 | 0.00 | -- | -- | -- | -113.46 | 141.94 | -199.60 | 173.06 | -- | -- | -- | -- | -- | -2.92 | -- | -- | -- | -- | 52.46 | -- | -- | -- |
| Evofem Biosciences Inc | 16.01m | 47.49m | 651.63k | 37.00 | 0.0011 | -- | 0.0137 | 0.0407 | -5.92 | -5.92 | 0.0826 | -1.36 | 0.935 | 1.72 | 2.73 | 432,756.80 | 295.02 | -211.64 | -- | -- | 63.65 | -- | 315.54 | -1,031.55 | 0.0757 | -2.91 | -- | -- | 8.20 | -- | 164.08 | -- | -10.59 | -- |
| Scisparc Ltd | 0.00 | -6.96m | 655.94k | 3.00 | -- | 26.93 | -- | -- | -1.22 | -1.51 | 0.00 | 0.0344 | 0.00 | -- | -- | 0.00 | -92.51 | -69.39 | -152.41 | -111.07 | -- | -- | -- | -527.17 | -- | -- | 0.9371 | -- | 113.73 | -- | -97.61 | -- | -- | -- |
| Sativus Tech Corp | 0.00 | -68.00k | 695.57k | -- | -- | -- | -- | -- | -0.0483 | -0.0483 | 0.00 | -0.5238 | 0.00 | -- | -- | -- | -18.83 | 25.48 | -- | -- | -- | -- | -- | -- | -- | -- | 5.41 | -- | -- | -- | 78.78 | -- | -- | -- |
| Neutra Corp | 17.40k | -474.98k | 729.47k | -- | -- | -- | -- | 41.92 | -0.0002 | -0.0002 | 0.00001 | -0.0003 | 0.2786 | 0.4126 | -- | -- | -758.75 | -682.94 | -- | -- | 46.15 | -- | -2,723.22 | -2,758.85 | 0.0009 | -14.06 | -- | -- | -26.09 | -- | 22.28 | -- | -- | -- |
Data as of Jun 04 2024. Currency figures normalised to Capstone Therapeutics Corp's reporting currency: US Dollar USD
3.28%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Ancora Alternatives LLCas of 31 Mar 2024 | 1.79k | 3.28% |
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
